Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

BACKGROUND: Increases in measured inulin clearance, measured creatinine clearance, and estimated glomerular filtration rate (eGFR) have been observed with bardoxolone methyl in 7 studies enrolling approximately 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). The largest o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Nephrol
Autori principali: Chin, Melanie P., Bakris, George L., Block, Geoffrey A., Chertow, Glenn M., Goldsberry, Angie, Inker, Lesley A., Heerspink, Hiddo J.L., O'Grady, Megan, Pergola, Pablo E., Wanner, Christoph, Warnock, David G., Meyer, Colin J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2018
Soggetti:
Original Report: Patient-Oriented, Translational Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841134/
https://ncbi.nlm.nih.gov/pubmed/29402767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486398
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi